Search results
Results from the WOW.Com Content Network
On September 14, 2016, Garraway was appointed the Senior Vice President of Global Oncology at Eli Lilly and Company, succeeding Richard Gaynor. [12] In October 2019, Garraway started his new leadership role as Roche Holding AG 's Chief Medical Officer. [ 7 ]
Eli Lilly pleaded guilty to a US federal criminal misdemeanor charge of illegally marketing Zyprexa, actively promoting the drug for off-label uses, particularly for the treatment of dementia in the elderly. [258] The $1.415 billion penalty included an $800 million civil settlement, a $515 million criminal fine, and forfeit assets of $100 ...
The aftermath of World War II saw an explosion in the discovery of new classes of antibacterial drugs [29] including the cephalosporins (developed by Eli Lilly based on the seminal work of Giuseppe Brotzu and Edward Abraham), [30] [31] streptomycin (discovered during a Merck-funded research program in Selman Waksman's laboratory [32]), the ...
Eli Lilly (LLY) and Innovent Biologics have announced encouraging interim analysis data from ORIENT-11 at the virtual IASLC World Conference on Lung Cancer (WCLC) 2020.The randomized, double-blind ...
Pfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by introducing a direct-to-consumer medicines platform under the brand “Pfizer for All.” The move ...
The service, called LillyDirect, comes on the back on extraordinary demand seen over the last year for powerful weight-loss drugs such as Novo Nordisk's Wegovy. The obesity drug market, forecast ...
He serves as vice-chair of Scientific Programs on the Damon Runyon Cancer Research Foundation Board of Directors and Chair of the Damon Runyon Physician-Scientist Training Award selection committee and is a member of the board of directors at Eli Lilly [8] and the Stand Up to Cancer scientific advisory committee. [10]
(Reuters) -Eli Lilly's weight-loss drug, Zepbound, drastically cut the risk of developing type 2 diabetes in overweight or obese pre-diabetic adults after three years of weekly injections, the ...